Figure 3.
Bubble plot of the significantly changed metabolic pathways for IHD patients compared to the non-CVD subjects. Each bubble represents the identified significantly changed metabolite, whereas its color indicates the involvement in the corresponding metabolic pathway, and its size corresponds to the magnitude of its p-value (the size of the bubble positively correlates with the p-value magnitude). The position of each bubble characterizes the value of log2FC between its concentration in IHD patients and subjects without CVD.